A Study to Evaluate Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets and Capsules

Recruiting

ElagolixA Study to Evaluate Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets and Capsules

Sponsor:

AbbVie

Code:

NCT04464187

Conditions

Endometriosis

Uterine Fibrioids

Eligibility Criteria

Sex: Female

Age: 0 - 70+

Healthy Volunteers: Not accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by AbbVie on 2024-06-18.